Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...

Precision Neuroscience Co-Founder and CEO Michael Mager discusses the changes coming to the healthcare and technology sectors ...

Food and Drug Administration’s blessing to fast-track its vision technology, called Blindsight, through the regulatory ...

Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

The first generation Neuralink device has 1000 electrodes and 100 electrodes are reading at about 10 bits per second per electrode. The second generation Neuralink device should have 3000 electrodes ...

"To my knowledge, this is the first time that restoration of the ability to fluently read has ever been definitively shown in ...

Tom Oxley, the Australian-born chief executive of brain chip company Synchron, has praised ­Donald Trump for having a ...

Elon Musk, known for his ventures in tech and space, takes on a new role in government. Discover how he balances multiple ...

The world's wealthiest man is the CEO of Tesla and SpaceX, and he has several other roles across his many companies.

Things are looking a little brighter now. In September, Neuralink received a "breakthrough device" designation from the Food and Drug Administration for its "Blindsight" brain implant, which Elon ...

Elon Musk suggested that Neuralink's brain implants could eventually be as affordable as an Apple Watch, aiming for mass ...